Full-Time

Team Lead Operations

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

Compensation Overview

$32.22 - $44.57/hr

Company Historically Provides H1B Sponsorship

Washington, DC, USA

Hybrid

Hybrid role with 20% travel.

Category
Business & Strategy (1)

Get referred to Stryker

Find people who can refer or advise you

Requirements
  • Basic computer skills including Microsoft Office, strong verbal and written communication, interpersonal, and organizational skills are essential.
  • Maintain professional appearance, work ethic, and attitude required by Stryker and the medical facility.
  • Must have near visual acuity (corrected) color vision, mobility, bending, standing, stooping, and finger dexterity.
  • Must be able to observe and correct minute inconsistencies (e.g. in the printed word, product appearance, etc.).
  • Excellent equipment problem-solving skills.
  • Must have CRCST Certification
  • Stryker Product experience
  • Bachelor’s Degree, Associate’s Degree or equivalent certifications preferred (Note: this item is listed under Education/Training Required but labeled as preferred)
  • Adhere to HIPAA and other related patient confidentiality policies.
Responsibilities
  • Effectively partners with key stakeholders of account, cross-divisional sales teams, and cross-functional teams to drive account productivity and satisfaction.
  • Leads Tier 1 huddles.
  • Actively participates in and as needed, leads hospital huddles.
  • Directs and guides day-to-day function of team to ensure OR efficiency and drive customer satisfaction.
  • Manages charge sheets and billing for account.
  • Directly applies feedback and metrics to propose process improvements that drive customer satisfaction and elevate Stryker’s impact on the account.
  • Provides in-service training at the request of the customer.
  • Supports and guides Sr. Specialists identifying and creating Kaizen sheets to drive continuous improvement.
  • Responsible for onboarding new employees.
  • Functional knowledge of SPD & OR; Significant understanding of surgeon preference.
  • Manages and coordinates Stryker and customer onboarding and compliance requirements for team.
  • Good understanding of Joint Commission requirements and managing that for the team and account.
  • Allocates work as a team leader; may check on quality/completion.
  • Attends and participates in several CE webinars throughout the year.
  • Actively partners with Associate Supervisor, Supervisor, OA and Training team to onboard new hires.
  • Serves as mentor to newer specialists in the area.
  • Assists with writing and delivering corrective action and common annual review.
  • Drives onboarding for new hires.
  • Serves as a resource for team and drives day-to-day engagement, performance and activities.
  • Leads Program Management activities within account.
  • Direct impact by ensuring the quality of the task/services/information provided by self and others.
  • Main point of contact for team account.
  • Proactively communicates out to appropriate stakeholders specific account information.
  • Actively provides ideas to refine tools or process.
  • Provides implementation and coverage support if/when practical.
  • Actively partners with fellow Team Leads across nation to drive standardization and continuous improvement across regional lines.
Desired Qualifications
  • Bachelor’s Degree, Associate’s Degree or equivalent certifications preferred

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Vascular division jumped 27.5% following Inari acquisition, boosting organic growth outlook.
  • Trident II Acetabular System launched in India, targeting rising hip replacement demand from aging populations.
  • Free cash flow rose 227% to $415 million, strengthening capital efficiency and investor returns.

What critics are saying

  • March 11, 2026 cyberattack by Handala disrupted global manufacturing, causing high-impact Q1 earnings miss.
  • BofA cut price target to $380 on medtech slowdown, reducing 2027 earnings estimates due to soft utilization.
  • Intuitive Surgical's 39x earnings vs Stryker's 22x risks valuation erosion in joint-replacement markets.

What makes Stryker unique

  • Pangea Plating System launched in Europe on May 26, 2026, addressing diverse fractures without plate bending.
  • Mako-driven orthopaedics franchise grows with integrated robotics for total joint and trauma procedures.
  • TPX HD power tool delivers 296% more torque for demanding orthopaedic revision surgeries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.